Shukra Pharmaceuticals shareholding pattern

Who owns itSep 2026 quarter

Promoters51.15%
Foreign investors (FII)0.44%
Domestic institutions (DII)0.22%
of which mutual funds0.00%
Public48.20%

Per cent of all shares. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SHUKRAPHAR₹64.48

Shukra Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersBPLPHARMAJENBURPHKPLMAKERSLNOVARTINDPARNAXLABSGRLSUNLOCMcap ₹52 Cr
Holding % of Total Shares
12 Months Ending
Q2 FY27
30/09/2026
Promoter & Group51.15
FII / FPI0.44
DII0.22
Latest: 2026-09-30 · 1 quarters of history · click a row to chart it.
« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.